Other languages Nautilus Biotechnology, Inc.

Equities

NAUT

US63909J1088

Market Closed - Nasdaq Other stock markets 02:00:01 04/05/2024 am IST			5-day change	1st Jan Change
2.69 ^USD	+0.75%		+8.03%	-10.03%

30/04	Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024
30/04	Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/23/31
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/23/02
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	02/23/02
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23/23/23
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23/23/23
Nautilus Biotechnology Expands to San Diego	26/23/26
Nautilus Biotechnology, Translational Genomics Research Institute Team Up to Advance Study in Childhood Cancer	19/23/19
Nautilus Biotechnology, Inc. Partners with the Translational Genomics Research Institute to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma	19/23/19
Nautilus Biotechnology, Inc. Appoints Karen Akinsanya to Nominating Committee	01/22/01
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	01/22/01
NAUTILUS : le fabricant de produits de fitness étudie la possibilité d'une vente	27/22/27
Exode chez Peloton, Biogen paye, Nautilus souffre, Meta s'excuse : Planète Bourse du mardi 27 septembre	27/22/27
Nautilus Biotechnology Shares Rise After Company's Q2 Loss Narrows	02/22/02
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	02/22/02
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	03/22/03
Nautilus Biotechnology, Inc. Appoints Gwen Weld as Chief People Officer	12/22/12
Nautilus Biotechnology, Inc. Appoints Karen Akinsanya to Board of Directors	01/22/01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nautilus Biotechnology, Inc.

Equities

NAUT

US63909J1088

Other languages

Filters